FIRST AMENDMENT TO SECURITIES PURCHASE AND SECURITY AGREEMENTSecurities Purchase and Security Agreement • November 22nd, 2021 • Evofem Biosciences, Inc. • Pharmaceutical preparations • New York
This First Amendment to Securities Purchase and Security Agreement (this “Amendment”) is entered into as of November 20, 2021 (the “Amendment Effective Date”) by and among Evofem Biosciences, Inc., a Delaware corporation (the “Company”), 667, L.P., Baker Bros. Life Sciences, L.P. (each, a “Purchaser”, and collectively, the “Purchasers”), and Baker Bros. Advisors LP, as agent and collateral agent for the Purchasers (in such capacity, the “Designated Agent”).
